Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Peringkat dalam Saham #33752
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Harga Saham
$0.4523
Terakhir disinkronkan: 2023-03-03
Kapitalisasi Pasar
$6.97M
Perubahan (1 hari)
-19.23%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Lucira Health, Inc. (LHDX)

Kategori

Rasio P/S untuk Lucira Health, Inc. (LHDX)
Rasio P/S per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Lucira Health, Inc., rasio P/S saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/S perusahaan adalah 0.
Riwayat rasio P/S untuk Lucira Health, Inc. dari 2026 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
8.10 -
US